Using a national sample of pharmaceutical products, this analysis estimates overall 340B growth, studies channel trends and the impact of contract pharmacy integrity programs. The report also estimates the impact of state bills mandating the use of contract pharmacies, and compares purchasing trends for the five largest disease areas.